AstraZeneca sold its stake in Moderna for over $1 billion: Report

British–Swedish pharma giant AstraZeneca has sold its 7.7% stake in drugmaker Moderna Inc for more than $1 billion after the US biotechnology company's shares soared on the back of its coronavirus vaccine breakthrough, The Times reported. However, it isn't clear over what period AstraZeneca sold its holding, the report added.
The news of the stake sale comes just after Johnson & Johnson’s single-shot coronavirus vaccine received approval as the third vaccine for emergency use in the US.